stockrowFulgent Genetics, Inc. (FLGT) vs Insight Molecular Diagnostics Inc. (IMDX)
- Fulgent Genetics, Inc. FLGT 18.66 −5.18%
- Insight Molecular Diagnostics Inc. IMDX 2.43 −8.30%
Fulgent Genetics, Inc. and Insight Molecular Diagnostics Inc. are both Diagnostics & Research companies. Fulgent Genetics, Inc. is the larger, with a market value of $513.4M against $80.5M — 6.4× the size. Fulgent Genetics, Inc. grew revenue faster over the last twelve months: 4.67% against −60.8%. Fulgent Genetics, Inc. has the higher net margin (−27.5% vs −2,955.6%) and the lower return on invested capital (−8.22% vs 0.00%). Across the 17 metrics below, Fulgent Genetics, Inc. leads on 10 and Insight Molecular Diagnostics Inc. on 7.
Valuation
Profitability
| Metric | FLGT | IMDX | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.82% | 48.32% | 48.32% |
| Operating margin | (39.20%) | (3,011.86%) | (5.68%) |
| Net margin | (27.53%) | (2,955.63%) | (4.10%) |
| Free cash flow margin | 4.37% | (1,856.23%) | 0.00% |
| Return on equity | (8.64%) | 488.68% | 0.00% |
| Return on assets | (7.93%) | (123.46%) | (6.05%) |
| Return on invested capital | (8.22%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack